Are you a new member? Sign up now
Login area
| Sign up
close
PRIORIX - - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J07BD52 | B | Rubella virus live attenuated - =10³ CCID50, Mumps virus live attenuated - =103.7 CCID50, Measles virus live attenuated - =10³ CCID50 | 3951 | 973739/02 | PRIORIX | 1 | Injectable lyophilised powder for solution+diluent | IM/SC | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 1,142,266 L.L | 23.08 | A2 | GlaxoSmithKline Biologicals SA | Belgium | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024